119-hr1432

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1432 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 1432

To prohibit any Federal law from making the manufacturer of a COVID-19 
 vaccine immune from suit or liability, or limiting the liability of 
such a manufacturer, with respect to claims for loss caused by, arising 
out of, relating to, or resulting from the administration to or the use 
 by an individual of a COVID-19 vaccine, and for other purposes.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 February 18, 2025

Mr. Roy (for himself, Mr. Massie, Mr. Brecheen, Mr. Cloud, Mr. Higgins 
 of Louisiana, Mr. Crane, Mr. Gosar, and Mr. Perry) introduced the 
 following bill; which was referred to the Committee on the Judiciary

_______________________________________________________________________

 A BILL

To prohibit any Federal law from making the manufacturer of a COVID-19 
 vaccine immune from suit or liability, or limiting the liability of 
such a manufacturer, with respect to claims for loss caused by, arising 
out of, relating to, or resulting from the administration to or the use 
 by an individual of a COVID-19 vaccine, and for other purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Let Injured Americans Be Legally 
Empowered Act'' or the ``LIABLE Act''.

SEC. 2. NO FEDERAL IMMUNITY FROM, OR LIMITATION ON, LIABILITY FOR 
 MANUFACTURERS FOR LOSS CAUSED BY A COVID-19 VACCINE.

    (a) In General.--No Federal law, including sections 319F-3, 2111, 
and 2122 of the Public Health Service Act (42 U.S.C. 247d-6d, 300aa-11, 
300aa-22), may make the manufacturer of a COVID-19 vaccine immune from 
suit or liability, or limit the liability of such a manufacturer, with 
respect to claims for loss caused by, arising out of, relating to, or 
resulting from the administration to or the use by an individual of a 
COVID-19 vaccine.

    (b) Rule of Construction.--Nothing in this Act shall be construed 
to prohibit an individual from seeking compensation through the 
Countermeasures Injury Compensation Program under 

section 319F-4 of the 
Public Health Service Act (42 U.S.C. 247d-6e) or the National Vaccine 
Injury Compensation Program under subtitle 2 of title XXI of such Act 
(42 U.S.C. 300aa-10 et seq.).
            (c) Relation to Other Programs.--An individual shall not be 
precluded from bringing a civil action for claims described in 
subsection

    (a) on the basis of such individual having sought or 
received compensation through the Countermeasures Injury Compensation 
Program under 

section 319F-4 of the Public Health Service Act (42 
U.S.C. 247d-6e) or the National Vaccine Injury Compensation Program 
under subtitle 2 of title XXI of such Act (42 U.S.C. 300aa-10 et seq.).
            (d) === Definition. ===
-The term ``COVID-19 vaccine'' means a vaccine 
licensed or otherwise authorized by the Food and Drug Administration to 
prevent, mitigate, or limit--

    (1) the harm from COVID-19; or

    (2) the transmission of SARS-CoV-2 or a virus mutating 
 therefrom.

    (e) Retroactive Applicability.--This Act applies without regard to 
whether the adminstration or use of a COVID-19 vaccine occurs before, 
on, or after the date of enactment of this Act.
 <all>